Tubercular involvement of pancreas is rare. It presents as a focal lesion of pancreas on cross sectional imaging. Endosonography with fine-needle aspiration (EUS-FNA) is important for a effectively timed presurgical evaluation.
A retrospective evaluation was carried out on 117 circumstances of pancreatic focal mass current course of EUS-FNA at our institution over a interval of three years, and 5 circumstances with pancreatic tuberculosis (TB) had been detected.
The medical presentation numerous from obstructive jaundice, recurrent acute pancreatitis to incidentaloma of pancreas. All victims acquired antitubercular treatment and had been adopted up for on the very least 6 months.
In conclusion, pancreatic tuberculosis is a differential of a pancreatic focal lesion and EUS-FNA is the technique for evaluation of this case that can obviate surgical exploration.

Mycobacterium tuberculosis-Explicit T Cell Purposeful, Memory, and Activation Profiles in QuantiFERON-Reverters Are Fixed With Managed An infectioN

Reversion of immune sensitization exams for Mycobacterium tuberculosis (M.tb) an an infection, resembling interferon-gamma launch assays or tuberculin pores and pores and skin test, has been reported in quite a few analysis.
We hypothesized that QuantiFERON-TB Gold (QFT) reversion is said to a decline of M.tb-specific helpful T cell responses, and a particular pattern of T cell and innate responses as compared with persistent QFT+ and QFT- individuals.
We in distinction groups of healthful adolescents (n=~30 each), outlined by 4, 6-monthly QFT exams: reverters (QFT+/+/-/-), non-converters (QFT-/-/-/-) and persistent positives (QFT+/+/+/+).
We stimulated peripheral blood mononuclear cells with M.tb antigens (M.tb lysate; CFP-10/ESAT-6 and EspC/EspF/Rv2348 peptide swimming swimming pools) and measured M.tb-specific adaptive T cell memory, activation, and helpful profiles; along with helpful innate (monocytes, pure killer cells), donor-unrestricted T cells (DURT: γδ T cells, mucosal-associated invariant T and pure killer T-like cells) and B cells by motion cytometry.
Projection to latent home discriminant analysis was utilized to seek out out choices that most interesting distinguished between QFT reverters, non-converters and persistent positives. No longitudinal modifications in immune responses to M.tb had been seen upon QFT reversion.
M.tb-specific Th1 responses detected in reverters had been of intermediate magnitude, bigger than responses in QFT non-converters and reduce than responses in persistent positives.
About one third of reverters had a robust response to CFP-10/ESAT-6. Amongst these with measurable responses, lower proportions of TSCM (CD45RA+CCR7+CD27+) and early differentiated (CD45RA-) IFN-γ-TNF+IL-2- M.tb lysate-specific CD4+ cells had been seen in reverters in distinction with non-converters.
Conversely, bigger proportions of early differentiated and reduce proportions of effector (CD45RA-CCR7-) CFP10/ESAT6-specific Th1 cells had been seen in reverters as compared with persistent-positives. No variations in M.tb-specific innate, DURT or B cell helpful responses had been seen between the groups.
Statistical modelling misclassified the overwhelming majority of reverters as non-converters additional usually than that they had been appropriately categorised as reverters or misclassified as persistent positives.
These findings suggest that QFT reversion occurs in a heterogeneous group of individuals with low M.tb-specific T cell responses. In some individuals QFT reversion may finish end result from assay variability, whereas in others the magnitude and differentiation standing of M.tb-specific Th1 cells are in line with well-controlled M.tb an an infection.
 Endoscopic ultrasonographic diagnosis of pancreatic tuberculosis in immunocompetent patients-A case series from eastern India

Disseminated Tuberculosis Associated With Adalimumab Treatment

Therapeutic blockade of tumour necrosis difficulty alpha (anti-TNF-α) is the mainstay remedy of quite a few rheumatologic sicknesses. They’re unfrequently associated to opportunistic infections and latent tuberculosis (TB) screening is paramount sooner than immunosuppression.
A 62-year-old man with psoriatic arthritis was beneath remedy with adalimumab for over 5 years. The screening for latent tuberculosis an an infection (LTBI) earlier to the start of immunosuppression was detrimental, and a subsequent interferon gamma launch assay 4 years later was moreover detrimental.
He launched inside the emergency division complaining of asthenia, anorexia, fever, night sweats and weight discount for over 5 months. He moreover complained of memory loss, no matter his common cognitive and neurological examination.
After an exhaustive workup, he was recognized with a disseminated tuberculosis (cerebral, pulmonary and peritoneal) and dealt with accordingly. TB evaluation stays troublesome in positive situations.
Latent TB screening exams may lack sensitivity and immunosuppressive treatment will improve the hazard of disseminated an an infection. We discuss in regards to the workup and administration of a central nervous system disseminated TB related to adalimumab treatment.
 Endoscopic ultrasonographic diagnosis of pancreatic tuberculosis in immunocompetent patients-A case series from eastern India

Distinction-Enhanced Ultrasound Imaging Choices of Focal Splenic Tuberculosis

BACKGROUND The aim of this look at was to characterize the contrast-enhanced ultrasound imaging choices of focal splenic tuberculosis. MATERIAL AND METHODS We retrospectively analyzed the usual ultrasound (US) and contrast-enhanced ultrasound (CEUS) imaging choices of 22 victims with splenic TB confirmed by surgical histopathology or biopsy.
RESULTS Typical US demonstrated that 15 of the 22 victims had a single lesion, whereas 7 had quite a few lesions. The utmost diameter of the lesions ranged from 1.zero to a few.7 cm. Of the 22, 17 had been detected with hypoecho and 5 had been detected with superior echo by typical US. Seven (7/22) had been detected with blood motion alerts by coloration Doppler motion image (CDFI).
CUES demonstrated that 18 circumstances (81.8%, 18/22) began to bolster inside the arterial part, principally adopted by gradual wash-out inside the intermediate or late parenchymal part, and 4 (18.2%, 4/22) launched with non-enhancement all through all phases.
The enhancement patterns had been categorized into 4 kinds: Variety I, homogeneous enhancement (2/22); Variety II, rim-like enhancement (12/22); Variety III, septation-like enhancement (4/22); and Variety IV, non-enhancement (4/22).
CONCLUSIONS CEUS confirmed that splenic TB lesions had been enhanced inside the arterial part, adopted by gradual washed out or persistent enhancement inside the intermediate and late parenchymal phases.
The rim- or septation-like enhancement may be helpful for diagnosing splenic TB. The splenic lesions presenting spherical hypoecho by typical US and full non-enhancement by CEUS are extraordinarily suspicious of splenic TB.

A high-frequency single nucleotide polymorphism inside the MtrB sensor kinase in medical strains of Mycobacterium tuberculosis alters its biochemical and physiological properties

The DNA polymorphisms current in medical strains of Mycobacterium tuberculosis drive altered physiology, virulence, and pathogenesis in them.
Although the lineages of these medical strains might be traced once more to frequent ancestor/s, there exists a plethora of distinction between them, in distinction to individuals who have developed inside the laboratory.
 Endoscopic ultrasonographic diagnosis of pancreatic tuberculosis in immunocompetent patients-A case series from eastern India
We decide a mutation present in ~80% of medical strains, which maps inside the HATPase space of the sensor kinase MtrB and alters kinase and phosphatase actions, and impacts its physiological perform.
The modifications conferred by the mutation had been probed by in-vitro biochemical assays which revealed modifications in signaling properties of the sensor kinase. These modifications moreover impact bacterial cell division costs, measurement and membrane properties.

Brucella Abortus Antigen

NAT41599-500 0.5
EUR 1176.24
Description: Brucella abortus lysate, produced by fermentation.

Candida Albicans Antigen

NAT41601-100 0.1
EUR 391.66
Description: Candida albicans is grown on solid medium, washed, disrupted and subjected to an extraction process. The antigen consists of cytoplasmic and cell wall components.

Candida Albicans Antigen

NAT41601-500 0.5
EUR 1176.24
Description: Candida albicans is grown on solid medium, washed, disrupted and subjected to an extraction process. The antigen consists of cytoplasmic and cell wall components.

Canine Parvovirus Antigen

NAT41594-100 0.1
EUR 391.66
Description: Canine Parvovirus, produced in CRFK cells.

Canine Coronavirus Antigen

NAT41590-100 0.1
EUR 391.66
Description: Canine Coronavirus produced in A-72 cells.

Feline Calicivirus Antigen

NAT41595-100 0.1
EUR 391.66
Description: Feline Calicivirus produced in FC 3TG cells.

Helicobacter Pylori Antigen

NAT41603-100 0.1
EUR 391.66
Description: Bacteria are cultured on solid medium, harvested, washed and solubilised. The antigen is partially purified by detergent extraction and centrifugation.

Helicobacter Pylori Antigen

NAT41603-500 0.5
EUR 1176.24
Description: Bacteria are cultured on solid medium, harvested, washed and solubilised. The antigen is partially purified by detergent extraction and centrifugation.

Campylobacter Jejuni Antigen

NAT41600-100 0.1
EUR 391.66
Description: Campylobacter jejuni is cultured on solid medium. This antigen is a partially purified detergent extract of the membrane fraction. The main component is an outer membrane protein, approximately 45 kDa in SDS-PAGE.

Campylobacter Jejuni Antigen

NAT41600-500 0.5
EUR 1176.24
Description: Campylobacter jejuni is cultured on solid medium. This antigen is a partially purified detergent extract of the membrane fraction. The main component is an outer membrane protein, approximately 45 kDa in SDS-PAGE.

Chlamydia Trachomatis Antigen

CT022-1000 1.0
EUR 378.9
Description: Chlamydia trachomatis antigens from clarified cell lysate.

Mycoplasma Pneumoniae Antigen

MP901-1000 1.0
EUR 1010.39
Description: Mycoplasma pneumoniae whole organisms that have been purified and detergent treated to enrich antigenic proteins and decrease background.

Mycoplasma Pneumoniae Antigen

MP901-200 0.2
EUR 270.46
Description: Mycoplasma pneumoniae whole organisms that have been purified and detergent treated to enrich antigenic proteins and decrease background.

Echovirus Antigen, Recombinant

REC31776-100 0.1
EUR 276.84
Description: Proprietary recombinant antigen expressed in E. coli and purified by chromatography. Individually pooled antigens shown to react with QC serum panel (multiple negative, borderline and positive sera) within defined reactivity range in Coxsackie-/Echovirus

Echovirus Antigen, Recombinant

REC31776-500 0.5
EUR 1043.56
Description: Proprietary recombinant antigen expressed in E. coli and purified by chromatography. Individually pooled antigens shown to react with QC serum panel (multiple negative, borderline and positive sera) within defined reactivity range in Coxsackie-/Echovirus

Neisseria Gonorrhoeae Antigen

NG01-1000 1.0
EUR 378.9
Description: Homogenised lysate of pure bacteria.

Trichomonas Vaginalis Antigen

TV01-1000 1.0
EUR 421
Description: Washed & lysed suspension of whole protozoa

Enterovirus Antigen, Recombinant

REC31772-100 0.1
EUR 276.84
Description: Proprietary recombinant antigen expressed in E. coli and purified by chromatography. Individually pooled antigens shown to react with QC serum panel (multiple negative, borderline and positive sera) within defined reactivity range in Coxsackie-/Echovirus IgA, IgG and IgM ELISA.

Enterovirus Antigen, Recombinant

REC31772-500 0.5
EUR 1043.56
Description: Proprietary recombinant antigen expressed in E. coli and purified by chromatography. Individually pooled antigens shown to react with QC serum panel (multiple negative, borderline and positive sera) within defined reactivity range in Coxsackie-/Echovirus IgA, IgG and IgM ELISA.

Echinococcus Granulosus Antigen

NAT41602-100 0.1
EUR 391.66
Description: Echinococcus granulosus material is derived from bovine hydatid cyst as sterile filtered cyst fluid.

Echinococcus Granulosus Antigen

NAT41602-500 0.5
EUR 1176.24
Description: Echinococcus granulosus material is derived from bovine hydatid cyst as sterile filtered cyst fluid.

Cytomegalovirus Purified Antigen

CMV-HP-100 0.1
EUR 318.94
Description: A concentrated source of human Cytomegalovirus particles purified by sucrose gradient ultracentrifugation.

Cytomegalovirus Purified Antigen

CMV-HP-1000 1.0
EUR 2096.06
Description: A concentrated source of human Cytomegalovirus particles purified by sucrose gradient ultracentrifugation.

Cytomegalovirus Purified Antigen

CMV-HP-500 0.5
EUR 1279.58
Description: A concentrated source of human Cytomegalovirus particles purified by sucrose gradient ultracentrifugation.

Astrovirus Antigen (Type 1)

AS02-1000 1.0
EUR 1654.65
Description: A concentrated source of Astrovirus particles and Astrovirus proteins from a lysate of host cells.

Astrovirus Antigen (Type 1)

AS02-200 0.2
EUR 442.69
Description: A concentrated source of Astrovirus particles and Astrovirus proteins from a lysate of host cells.

Yersinia pestis V antigen

REC32028-100 0.1
EUR 491.53
Description: Yersinia pestis V antigen (LcrV antigen, capsule protein fraction 1, type III secretion system needle tip protein). The protein is produced as an N-terminal GST fusion, with GST being cleaved by thrombin and is not present in the final product.

Yersinia pestis V antigen

REC32028-500 0.5
EUR 2421.37
Description: Yersinia pestis V antigen (LcrV antigen, capsule protein fraction 1, type III secretion system needle tip protein). The protein is produced as an N-terminal GST fusion, with GST being cleaved by thrombin and is not present in the final product.

Canine Herpes Virus Antigen

NAT41592-100 0.1
EUR 391.66
Description: Canine Herpes virus, produced in MDCK cells.

Canine Adenovirus 1 Antigen

NAT41587-100 0.1
EUR 391.66
Description: Canine Adenovirus Type 1, produced in A-72 cells.

Canine Adenovirus 2 Antigen

NAT41588-100 0.1
EUR 391.66
Description: Canine Adenovirus Type 2, produced in A-72 cells.

Canine Distemper Virus Antigen

NAT41591-100 0.1
EUR 391.66
Description: Canine Distemper virus, produced in SL-29 cells.

Norovirus GII.4 VP1 Antigen

REC31620-100 0.1
EUR 302.36
Description: Recombinant Norovirus GII.4 VP1 antigen produced in 293 human cells.

Norovirus GII.4 VP1 Antigen

REC31620-1000 1.0
EUR 1830.71
Description: Recombinant Norovirus GII.4 VP1 antigen produced in 293 human cells.

Norovirus GII.4 VP1 Antigen

REC31620-500 0.5
EUR 1066.53
Description: Recombinant Norovirus GII.4 VP1 antigen produced in 293 human cells.

Canine Parainfluenza Virus Antigen

NAT41593-100 0.1
EUR 391.66
Description: Canine Parainfluenza virus antigen, produced in MDCK cells.

Feline Panleukopenia Virus Antigen

NAT41597-100 0.1
EUR 391.66
Description: Feline Panleukopenia Virus (FPLV; feline parvovirus) antigen, produced in CRFK cells.

Cytomegalovirus Cell Lysate Antigen

CMV-CL-100 0.1
EUR 223.26
Description: A clarified cell lysate containing a mix of CMV antigens from all stages of the replication life cycle.

Cytomegalovirus Cell Lysate Antigen

CMV-CL-1000 1.0
EUR 1422.47
Description: A clarified cell lysate containing a mix of CMV antigens from all stages of the replication life cycle.

Feline Viral Rhinotracheitis Antigen

NAT41598-100 0.1
EUR 391.66
Description: Feline Viral Rhinotracheitis (FVR; feline herpes virus, FHV-1) antigen, produced in CRFK cells.

Herpes Simplex Virus 1 Antigen

HS105-1000 1.0
EUR 1178.79
Description: HSV-1 particles from a cell lysate are purified by sucrose gradient ultracentrifugation.

Herpes Simplex Virus 1 Antigen

HS105-200 0.2
EUR 294.7
Description: HSV-1 particles from a cell lysate are purified by sucrose gradient ultracentrifugation.

Herpes Simplex Virus 2 Antigen

HS205-1000 1.0
EUR 1178.79
Description: HSV-2 particles from a cell lysate are purified by sucrose gradient ultracentrifugation.

Herpes Simplex Virus 2 Antigen

HS205-200 0.2
EUR 294.7
Description: HSV-2 particles from a cell lysate are purified by sucrose gradient ultracentrifugation.

Ross River Virus Recombinant Antigen

REC31969-100 0.1
EUR 757.8
Description: Recombinant Ross River virus antigen expressed in HEK293 cells as virus-like particles and purified by sucrose density gradients and precipitation. Virus-like particles were then solubilized in PBS containing 0.2% SDS to prevent aggregation of particles. The preparation is not particulate. Antigens in the preparation include Envelope proteins 1 and 2 and Nucleoprotein.

Ross River Virus Recombinant Antigen

REC31969-500 0.5
EUR 2844.92
Description: Recombinant Ross River virus antigen expressed in HEK293 cells as virus-like particles and purified by sucrose density gradients and precipitation. Virus-like particles were then solubilized in PBS containing 0.2% SDS to prevent aggregation of particles. The preparation is not particulate. Antigens in the preparation include Envelope proteins 1 and 2 and Nucleoprotein.

Hepatitis B Virus E Antigen (HBeAg)

REC31677-100 0.1
EUR 456.72
Description: Recombinant Hepititis B Virus E Protein (HBeAg).

Hepatitis B Virus E Antigen (HBeAg)

REC31677-500 0.5
EUR 1941.06
Description: Recombinant Hepititis B Virus E Protein (HBeAg).

Canine Adenovirus 1 and 2 Antigen

NAT41589-100 0.1
EUR 391.66
Description: A mixture of Canine Adenovirus Type 1 and Type 2, produced in A-72 cells.

Hepatitis B Virus Core Antigen (HBcAg)

REC31689-100 0.1
EUR 456.72
Description: Recombinant Hepititis B Virus Core Protein (HBcAg).

Hepatitis B Virus Core Antigen (HBcAg)

REC31689-500 0.5
EUR 1370.16
Description: Recombinant Hepititis B Virus Core Protein (HBcAg).

Hepatitis C Virus Core Antigen (HCcAg)

REC31693-100 0.1
EUR 484.79
Description: Recombinant Hepatitis C Virus core protein is produced in E. coli and fused with a His-tag.

Hepatitis C Virus Core Antigen (HCcAg)

REC31693-500 0.5
EUR 1455.64
Description: Recombinant Hepatitis C Virus core protein is produced in E. coli and fused with a His-tag.

Herpes Simplex Virus 1 Lysate Antigen

HS104-1000 1.0
EUR 270.46
Description: A high concentration of HSV-1 particles and proteins from a clarified cell lysate.

Herpes Simplex Virus 2 Lysate Antigen

HS204-1000 1.0
EUR 270.46
Description: A high concentration of HSV-2 particles and proteins from a clarified cell lysate.

Feline Infectious Peritonitis Virus Antigen

NAT41596-100 0.1
EUR 391.66
Description: Feline Infectious Peritonitis virus (FIPV; feline coronavirus) antigen, produced in CRFK cells.

Legionella pneumophila antigen (native extract)

NAT41580-100 0.1
EUR 391.66
Description: Inactivated Legionella pneumophila antigen from culture.

Streptococcus Pneumoniae Antigen, Native Extract

NAT41604-100 0.1
EUR 391.66
Description: Inactivated Streptococcus pneumoniae antigen from culture.

Leptospira Biflexa Antigen (Strain Patoc 1)

NAT41582-100 0.1
EUR 391.66
Description: Inactivated Leptospira biflexa antigen (Strain Patoc 1) from broth culture.

Leptospira Biflexa Antigen (Strain Patoc 1)

NAT41582-500 0.5
EUR 1176.24
Description: Inactivated Leptospira biflexa antigen (Strain Patoc 1) from broth culture.

Mouse Anti-Hepatitis B Surface Antigen Antibody (1834)

MAB12230-100 0.1
EUR 275.56
Description: Mouse monoclonal antibody specific for Hepatitis B virus surface antigen (1834).

Mouse Anti-Hepatitis B Surface Antigen Antibody (1837)

MAB12231-100 0.1
EUR 275.56
Description: Mouse monoclonal antibody specific for Hepatitis B virus surface antigen (1837)

Mouse Anti-Hepatitis B Surface Antigen Antibody (1838)

MAB12232-100 0.1
EUR 275.56
Description: Mouse monoclonal antibody specific for Hepatitis B virus surface antigen (1838)

Mouse Anti-Hepatitis B Virus E Antigen Antibody (1892)

MAB12226-100 0.1
EUR 275.56
Description: Mouse monoclonal antibody specific for Hepatitis B virus e antigen (1892)

Mouse Anti-Hepatitis B Virus E Antigen Antibody (1893)

MAB12227-100 0.1
EUR 275.56
Description: Mouse monoclonal antibody specific for Hepatitis B virus e antigen (1893)

Mouse Anti-Hepatitis B Virus E Antigen Antibody (1894)

MAB12228-100 0.1
EUR 275.56
Description: Mouse monoclonal antibody specific for Hepatitis B virus e antigen (1894)

Mouse Anti-Hepatitis B Virus E Antigen Antibody (M132)

MAB12298-100 0.1
EUR 276.84
Description: Mouse monoclonal antibody specific for Hepatitis B virus e antigen (M132)

Mouse Anti-Hepatitis B Virus E Antigen Antibody (M132)

MAB12298-500 0.5
EUR 695.29
Description: Mouse monoclonal antibody specific for Hepatitis B virus e antigen (M132)

Mouse Anti-Hepatitis B Virus E Antigen Antibody (M133)

MAB12299-100 0.1
EUR 276.84
Description: Mouse monoclonal antibody specific for Hepatitis B virus e antigen (M133)

Mouse Anti-Hepatitis B Virus E Antigen Antibody (M133)

MAB12299-500 0.5
EUR 695.29
Description: Mouse monoclonal antibody specific for Hepatitis B virus e antigen (M133)

Yersinia pestis chain B F1 capsule antigen, C-terminal His-tag

REC32027-100 0.1
EUR 491.53
Description: Yersinia pestis chain B F1 capsule antigen (Antig_Caf1)

Yersinia pestis chain B F1 capsule antigen, C-terminal His-tag

REC32027-500 0.5
EUR 2421.37
Description: Yersinia pestis chain B F1 capsule antigen (Antig_Caf1)

Mycobacterium Tuberculosis major secretory protein Antigen 85A Protein

20-abx262511
  • Ask for price
  • Ask for price
  • Ask for price
  • 10 ug
  • 1 mg
  • 2 µg

Mycobacterium Tuberculosis major secretory protein Antigen 85A Protein

abx262511-10mg 10 mg
EUR 325

Mycobacterium Tuberculosis major secretory protein Antigen 85A Protein

abx262511-25mg 25 mg
EUR 6575

Mycobacterium Tuberculosis major secretory protein Antigen 85A Protein

abx262511-5mg 5 mg
EUR 225

Mycobacterium Tuberculosis major secretory protein Antigen 85A Recombinant

rAP-3658 Inquiry Ask for price

Ag85A Mycobacterium Tuberculosis major secretory protein Antigen 85A Recombinant Protein

PROTP0A4V2 Regular: 10ug
EUR 380.4
Description: Recombinant Mycobacterium tuberculosis Ag85A (43-338 a.a) produced in Hi-5 cells is a single, glycosylated polypeptide chain having a molecular mass of 32.8kDa (305 a.a in total).;Antigen 85A is fused to a His tag at C-terminus and purified by conventional chromatographic techniques.

Cancer Antigen 242 Antigen

VAng-Cr3876-10kU 10 kU
EUR 505.2
Description: Cancer Antigen 242 Antigen, Host/Source: Metastatic Liver. The purity is detected by gel filtration.

HCV NS3 1359-1456aa antigen

00154-V-01mg 0,1 mg
EUR 321
Description: HCV NS3 1359-1456aa antigen. The protein contains immunodominant regions (1359-1456aa). available genotypes: 1a, 1b, 2b, 3, 4, 5, 6

HCV NS3 1359-1456aa antigen

00154-V-1000ug 1000 ug
EUR 1539
Description: HCV NS3 1359-1456aa antigen. The protein contains immunodominant regions (1359-1456aa). available genotypes: 1a, 1b, 2b, 3, 4, 5, 6

A549 HCP Control Antigen

F237 50 ul
EUR 308.4
Description: A549 HCP Control Antigen by Cygnus Technologies is available in Europe via Gentaur.

CEA Antigen (Antigen Grade)

GWB-378447 1 mg Ask for price

Cancer Antigen 50 Antigen

VAng-Cr3877-50kU 50 kU
EUR 6642
Description: Cancer Antigen 50 Antigen, Host/Source: Human Cell Culture. It is tested negative for HBsAg, antibodies to HCV and HIV 1/2.

Antigen 85-A Antibody (HRP)

20-abx109227
  • Ask for price
  • Ask for price
  • Ask for price
  • Ask for price
  • Ask for price
  • 100 ug
  • 1 mg
  • 200 ug
  • 20 ug
  • 50 ug

Cancer Antigen 72-4 Antigen

VAng-Cr3878-10kU 10 kU
EUR 505.2
Description: Cancer Antigen 72-4 Antigen, Host/Source: Metastatic Liver. The purity is ~65% by SDS-PAGE. It is tested negative for HBsAg, antibodies to HCV and HIV 1/2.

Antigen 85-A Antibody (FITC)

20-abx107809
  • Ask for price
  • Ask for price
  • Ask for price
  • Ask for price
  • Ask for price
  • 100 ug
  • 1 mg
  • 200 ug
  • 20 ug
  • 50 ug

Antigen 85-A (fbpA) Antibody

abx110661-100l 100 µl
EUR 162.5

Antigen 85-A (Ag85A) Antibody

20-abx110661
  • Ask for price
  • Ask for price
  • Ask for price
  • Ask for price
  • Ask for price
  • 100 ug
  • 1 mg
  • 200 ug
  • 20 ug
  • 50 ug

A549 HCP Antigen Concentrate

F233G 200 ul
EUR 540
Description: A549 HCP Antigen Concentrate by Cygnus Technologies is available in Europe via Gentaur.

Antigen 85-A Antibody (Biotin)

20-abx106397
  • Ask for price
  • Ask for price
  • Ask for price
  • Ask for price
  • Ask for price
  • 100 ug
  • 1 mg
  • 200 ug
  • 20 ug
  • 50 ug

Cell surface A33 antigen

AP78971 1mg
EUR 2640

Cell surface A33 antigen

AP83694 1mg
EUR 2640

Antigen 85-A (fbpA) Antibody (HRP)

abx109227-100l 100 µl
EUR 162.5

Antigen 85-A (fbpA) Antibody (FITC)

abx107809-100g 100 µg
EUR 362.5

Antigen 85-A (fbpA) Antibody (FITC)

abx107809-20g 20 µg
EUR 162.5

Antigen 85-A (fbpA) Antibody (FITC)

abx107809-50g 50 µg
EUR 250

Cancer Antigen 125 Antigen (Ascites Fluid)

VAng-Cr3870-10kU 10 kU
EUR 1132.8
Description: Cancer Antigen 125 Antigen, Host/Source: Ascites Fluid. The purity is ≥ 95% by SDS-PAGE.

Antigen 85-A (fbpA) Antibody (Biotin)

abx106397-100g 100 µg
EUR 362.5

Antigen 85-A (fbpA) Antibody (Biotin)

abx106397-20g 20 µg
EUR 162.5

Antigen 85-A (fbpA) Antibody (Biotin)

abx106397-50g 50 µg
EUR 250

HCV NS4 1916-1947aa recombinant antigen.

00156-V 1 MG
EUR 850

HCV NS4 1916-1947aa recombinant antigen

00156-V-01mg 0,1 mg
EUR 321
Description: HCV NS4 1916-1947aa recombinant antigen.

HCV NS4 1916-1947aa recombinant antigen

00156-V-1000ug 1000 ug
EUR 1539
Description: HCV NS4 1916-1947aa recombinant antigen.

HCV NS4 1916-1947aa recombinant antigen.

00156-V-100ugvial 100 ug/vial
EUR 150
Description: HCV NS4 1916-1947aa recombinant antigen.

HCV NS5 2061-2302aa recombinant antigen.

00157-V 1 MG
EUR 850

HCV NS5 2061-2302aa recombinant antigen

00157-V-01mg 0,1 mg
EUR 321
Description: HCV NS5 2061-2302aa recombinant antigen.

HCV NS5 2061-2302aa recombinant antigen

00157-V-1000ug 1000 ug
EUR 1539
Description: HCV NS5 2061-2302aa recombinant antigen.

HCV NS5 2061-2302aa recombinant antigen.

00157-V-100ugvial 100 ug/vial
EUR 150
Description: HCV NS5 2061-2302aa recombinant antigen.

HCV NS5 2212-2313aa recombinant antigen

00158-V-01mg 0,1 mg
EUR 321
Description: HCV NS5 2212-2313aa recombinant antigen. Available genotypes: 1a, 1b, 2a, 2b, 3a, 3b, 4, 5, 6a.

HCV NS5 2212-2313aa recombinant antigen

00158-V-1000ug 1000 ug
EUR 1539
Description: HCV NS5 2212-2313aa recombinant antigen. Available genotypes: 1a, 1b, 2a, 2b, 3a, 3b, 4, 5, 6a.

Cancer Antigen 125 Antigen (Human Adenocarcinoma)

VAng-Cr3868-10kU 10 kU
EUR 505.2
Description: Cancer Antigen 125 Antigen, Host/Source: Human Adenocarcinoma. The purity is detected by salt extraction and chromatography.

Human carcinoembryonic antigen (CEA) antigen

CEA15-N-100 100 ug
EUR 270

HCV core 2-119aa recombinant antigen

00150-V-01mg 0,1 mg
EUR 321
Description: HCV core 2-119aa recombinant antigen. Genotypes available: 1a, 1b, 2a, 2b, 3a, 3b, 3/10, 4, 5, 6a

HCV core 2-119aa recombinant antigen

00150-V-1000ug 1000 ug
EUR 1539
Description: HCV core 2-119aa recombinant antigen. Genotypes available: 1a, 1b, 2a, 2b, 3a, 3b, 3/10, 4, 5, 6a

Mouse Anti-Adenovirus Antibody (A114)

MAB12510-100 0.1
EUR 275.56
Description: Mouse monoclonal antibody specific for Adenovirus (clone A114).

Mouse Anti-Adenovirus Antibody (A114)

MAB12510-500 0.5
EUR 964.47
Description: Mouse monoclonal antibody specific for Adenovirus (clone A114).

Mouse Anti-Adenovirus Antibody (A115)

MAB12511-100 0.1
EUR 275.56
Description: Mouse monoclonal antibody specific for Adenovirus (clone A115).

Mouse Anti-Adenovirus Antibody (A115)

MAB12511-500 0.5
EUR 964.47
Description: Mouse monoclonal antibody specific for Adenovirus (clone A115).

Mouse Anti Canine Parvovirus 2 Antibody (2A10)

MAB12402-100 0.1
EUR 275.56
Description: Mouse monoclonal antibody specific for Canine Parvovirus 2 (2A10).

Mouse Anti Canine Parvovirus 2 Antibody (2A10)

MAB12402-500 0.5
EUR 691.46
Description: Mouse monoclonal antibody specific for Canine Parvovirus 2 (2A10).

Cancer Antigen CEA Antigen (Human Fluids)

VAng-Wyb8644-inquire inquire Ask for price
Description: Carcinoembryonic Antigen, Calibrator Grade, Cancer antigen from Human Fluids, 1.13 mg/mL.
The look at highlights the have an effect on of DNA polymorphisms on the pathophysiology of medical strains and provides insights into underlying mechanisms that drive signal transduction in pathogenic micro organism.

LEAVE A REPLY

Please enter your comment!
Please enter your name here